Related Experiment Video
Updated: Jun 22, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
Novel Peri-Operative Strategy for Sickle Cell Disease with Tetralogy of Fallot
Naveed Khan1, Vaibhav Dhabe1, Ameya Kaskar2
1Department of Cardiac Anesthesia, NH SRCC Children's Hospital, Mumbai, Maharashtra, India.
Annals of Cardiac Anaesthesia
|July 4, 2024
Summary
Managing cyanotic heart disease in sickle cell disease (SCD) patients requires careful planning. This case highlights successful intracardiac repair by optimizing hemoglobin S levels through transfusions and normothermic cardiopulmonary bypass.
Area of Science:
- Cardiology
- Hematology
- Anesthesiology
Background:
- Peri-operative management of patients with cyanotic congenital heart disease (CCHD) and sickle cell disease (SCD) presents unique challenges.
- Sickle cell disease increases the risk of vaso-occlusive crises, particularly during the physiological stress of surgery.
Observation:
- A case of Tetralogy of Fallot with homozygous SCD, a history of multiple blood transfusions, and recurrent sickle cell crises is presented.
- The patient underwent successful intracardiac repair.
Findings:
- A multi-modal strategy involving pre-operative blood transfusion, intraoperative exchange transfusion, and normothermic cardiopulmonary bypass (CPB) significantly reduced Hemoglobin S levels from 75% pre-operatively to 21.8% post-operatively.
- This approach effectively mitigated the risk of sickling crises during the peri-operative period.
Implications:
- Pre-operative optimization and meticulous intraoperative management are crucial for successful surgical outcomes in patients with co-existing CCHD and SCD.
- This case demonstrates a viable strategy for managing complex hematological and cardiac conditions simultaneously.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
195
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
195
Pneumonia IV: Management
317
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
317
Acute Respiratory Failure-V
129
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
129
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K

